PTC Therapeutics PTCT Gain Loss On Disposition And Impairment Of Tangible Assets
Gain Loss On Disposition And Impairment Of Tangible Assets at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept ptct:GainLossOnDispositionAndImpairmentOfTangibleAssets.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's gain loss on disposition and impairment of tangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's gain loss on disposition and impairment of tangible assets?
- PTC Therapeutics (PTCT) reported gain loss on disposition and impairment of tangible assets of -$927K in Q1 2026.
- How has PTC Therapeutics's gain loss on disposition and impairment of tangible assets changed year-over-year?
- PTC Therapeutics's gain loss on disposition and impairment of tangible assets decreased by 1103.9% year-over-year, from -$77K to -$927K.
- What does gain loss on disposition and impairment of tangible assets mean?
- This metric captures the net financial impact of selling, retiring, or writing down the carrying value of tangible fixed assets like property, plant, and equipment. It reflects the difference between the proceeds received from asset disposals and their book value, or the recognition of impairment losses when asset values decline. This provides insight into the company's capital asset management and the potential obsolescence of its physical infrastructure.